Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with the prognosis of the patients

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2605-2614

  Utsunomiya, Tamiharu ^b   Yonezawa, Suguru ^a,b   Sakamoto, Hideie ^b   Kitamura, Hiroshi ^b   Hokita, Shuichi ^b   Aiko, Takashi ^b   Tanaka, Sadao ^c   Irimura, Tatsuro ^d   Kim, Young S ^e   Sato, Eiichi ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Kagoshima City Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STOMACH CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; FEMALE; GASTRIC MUCOSA; GLYCOSYLATION; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCINS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0031756619     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Sakamoto, H., Yonezawa, S., Tanaka, S., Kim, Y. S., and Sato, E. Mucin antigen expression in gastric carcinomas of young and old adults. Hum. Pathol., 28: 1056-1065, 1997.
2. Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., and Kufe, D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc. Natl. Acad. Sci. USA, 85: 2320-2323, 1988.
3. Burchell, J., Gendler, S., Taylor-Papadimitriou, J., Girling, A., Lewis, A., Millis, R., and Lamport, D. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res., 47: 5476-5482, 1987.
4. Burchell, J., and Taylor-Papadimitriou, J. Effect of modification of carbohydrate side chains on the reactive of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol., 2: 155-162, 1993.
5. Girling, A., Bartkova, J., Burchell, J., Gendler, S., Gillett, C., and Taylor-Papadimitriou, J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer, 43: 1072-1076, 1989.
6. Burchell, J., Taylor-Papadimitriou, J., Boshell, M., Gendler, S., and Duhig, T. A short sequence within the amino acid tandem repeat of a cancer-associated mucin contains immunodominant epitopes. Int. J. Cancer, 44: 691-696, 1989.
7. Hull, S. R., Bright, A., Carraway, K. L., Abe, M., Hayes, D. F., and Kufe, D. W. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun., 1: 261-267, 1989.
8. Nakamori, S., Ota, D. M., Cleary, K. R., Shirotani, K., and Irimura, T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology, 106: 353-361, 1994.
9. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma, First English Edition. Tokyo, Japan: Kanehara & Co., Ltd., 1995.
10. Yamamoto, M., Bhavanandan, V. P., Nakamori, S., and Irimura, T. A novel monoclonal antibody specific for sialylated MUC1 mucin. Jpn. J. Cancer Res., 87: 488-496, 1996.
11. Taylor-Papadimitriou, J., Peterson, J. A., Arklie, J., Burchell, J., Ceriani, R. L., and Bodmer, W. S. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int. J. Cancer, 28: 17-21, 1981.
12. Burchell, J., Durbin, H., and Taylor-Papadimitriou, J. Complexity of expression of antigenic determinants recognized by monoclonal antibodies HMFG-1 and HMFG-2 in normal and malignant human mammary epithelial cells. J. Immunol., 131: 508-513, 1983.
13. Hsu, S. M., Gaine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577-580, 1981.
14. Yamashita, K., Yonezawa, S., Tanaka, S., Shirahama, H., Sakoda, K., Imai, K., Xing, P. X., McKenzie, I. F., Hilkens, J., Kim, Y. S., and Sato, E. Immunohistochemical study of mucin carbohydrates and core protein in hepatolithiasis and cholangiocarcinoma. Int. J. Cancer, 55: 82-91, 1993.
15. Osako, M., Yonezawa, S., Siddiki, B., Huang, J., Ho, J. J. L., Kim, Y. S., and Sato, E. Immunohistochemical study of mucin carbohydrates and core protein in human pancreatic tumors. Cancer (Phila.), 71: 2191-2199, 1993.
16. Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., and Burchell, J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol. Chem., 263: 12820-12823, 1988.
17. Gendler, S. J., Lancaster, C. A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Lalani, E. N., and Wilson, D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem., 265: 15286-15293, 1990.
18. Wreschner, D. H., Tsarfaty, I., Hareuveni, M., Zaretsky, J., Smorodinsky, N., Weiss, M., Horev, J., Kotkes, P., Zrihan, S., Jeltsch, J. M., Green, S., Lathe, R., and Keydar, I. Isolation and characterization of full length cDNA coding for the H23 breast tumor associated antigen. In: M. H. Rich, J. A. Hager, and I. Kevdar (eds.), Breast Cancer: Progress in Biology, Clinical Management and Prevention, pp. 41-60. Amsterdam, the Netherlands: Kluwer Academic Publishers, 1989.
19. Wreschner, D. H., Hareuveni, M., Tsarfaty, I., Smorodinsky, N., Horev, J., Zaretsky, J., Kotkes, P., Weiss, M., Lathe, R., Dion, A., and Keydar, I. Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur. J. Biochem., 189: 463-473, 1990.
20. Ligtenberg, M. J. L., Vos, H. L., Gennisen, A. M. C., and Hilkens, J. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem., 265: 5573-5578, 1990.
21. Lan, M. S., Batra, S. K., Qi, W., Metzgar, R. S., and Hollingsworth, M. A. Cloning and sequencing of a human pancreatic mucin cDNA. J. Biol. Chem., 265: 15294-15299, 1990.
22. Ligtenberg, M. J. L., Buijs, F., Vos, H. L., and Hilkens, J. Suppression of cellular aggregation by high level of episialin. Cancer Res., 52: 2318-2324, 1992.
23. Makiguchi, Y., Hinoda, Y., and Imai, K. Effect of MUC1 mucin and anti-adhesion molecule on tumor cell growth. Jpn. J. Cancer Res., 87: 505-511, 1996.
24. Suwa, T., Hinoda, Y., Makiguchi, Y., Takahashi, T., Itoh, F., Adachi, M., Hareyama, M., and Imai, K. Increased invasiveness of MUC1 cDNA-transfected human gastric cancer MKN74 cells. Int. J. Cancer, 76: 377-382, 1998.
25. Davessar, K., Pezzulo, J. C., Kessimian, N., Hale, J. H., and Jauregui, H. O. Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum. Pathol., 21: 325-332, 1990.
26. Moutinho, R. M., Sarmento, J. A., Sobrinho, S. M. A., and Bastos, J. Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma. Cancer (Phila.), 47: 780-784, 1981.
27. Stemmermann, G. N., and Brown, C. A survival study of intestinal and diffuse types of gastric carcinoma. Cancer (Phila.), 33: 1190-1195, 1974.
28. Barnd, D. L., Lan, M., Metzgar, R. S., and Finn, O. J. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA, 86: 7159-7163, 1989.
29. Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor-Papadimitriou, J., McKenzie, I. F., Bast, R. C., Jr., and Finn, O. J. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present of the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res., 51: 2908-2916, 1991.
30. Jerome, K. R., Bu, D., and Finn, O. J. Expression of tumor-associated epitopes of Epstein-Barr virus-immortalized B-cells and Burkitts's lymphomas transfected with epithelial mucin complementary DNA. Cancer Res., 52: 5985-5990, 1992.
31. Jerome, K. R., Domenech, N., and Finn, O. J. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J. Immunol., 151: 1654-1662, 1993.
32. Ban, T., Imai, K., and Yachi, A. Immunohistological and immunochemical characterization of a novel pancreatic cancer-associated antigen. MUSE11, Cancer Res., 49: 7141-7146, 1989.
33. Hinoda, Y., Nakagawa, N., Ohe, Y., Kakiuchi, H., Tsujisaki, M., Imai, K., and Yachi, A. Recognition of the polypeptide core of mucin by monoclonal antibody MUSE11 against an adenocarcinoma-associated antigen. Jpn. J. Cancer Res., 81: 1206-1209, 1990.
34. Hilkens, J., Buijs, F., Hilgers, J., Hageman, P., Calafat, J., Sonnenberg, A., and Van Der Valk, M. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int. J. Cancer, 34: 197-206, 1984.
35. Hilkens, J., Kroezen, V., Bonfrer, J. M. G., De Jong-Bakker, M., and Bruning, P. F. MAM-6 antigen, a new serum marker for breast cancer monitoring. Cancer Res., 46: 2582-2587, 1986.
36. Hilkens, J., and Buijs, F. Biosynthesis of MAM-6, an epithelial sialomucin. J. Biol. Chem., 263: 4215-4222, 1988.
37. Hilkens, J., Kroezen, V., Buijs, F., Hilgers, J., Van Der Vilet, M., De Voogd, W., Bonfrer, J., and Bruning, P. F. MAM-6, a carcinoma associated marker: preliminary characterization and detection in sera of breast cancer patients. In: R. L. Ceriani and M. Nijhoff (eds.), Monoclonal Antibodies and Breast Cancer, pp. 28-42. Hague, the Netherlands: Martinus Nijhoff, 1985.
38. Rinsum, J. V., Smets, L. A., Rooy, H. V., and Van Den Eijnden, D. H. Specific inhibition of human natural killer cell-mediated cytotoxicity by sialic acid and sialooligosaccharides. Int. J. Cancer, 38: 915-922, 1986.
39. Moriarty, J., Skelly, C. M., Bharathan, S., Moody, C. E., and Sherblom, A. P. Sialomucin and lytic susceptibility of rat mammary tumor ascites cells. Cancer Res., 50: 6800-6805, 1990.
40. Ogata, S., Maimonis, P. J., and Itzkowitz, S. H. Mucins bearing the cancer-associated sialosyl-Tn antigen mediated inhibition of natural killer cell cytotoxicity. Cancer Res., 52: 4741-4746, 1992.
41. Irimura, T., Mclsaac, A. M., Carlson, D. A., Yagita, M., Grimm, E. A., Menter, D., Ota, D. M., and Cleary, K. R. Soluble factor in normal tissues that stimulates high molecular weight sialoglycoprotein produced by human colon carcinoma cells. Cancer Res., 50: 3331-3338, 1990.
42. Irimura, T., Nakamori, S., Matsushita, Y., Taniuchi, Y., Todoroki, N., Tsuji, T., Izumi, Y., Kawamura, Y., Hoff, S. D., Cleary, K. R., and Ota, D. M. Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-Lex antigens. Semin. Cancer Biol., 4: 319-324, 1993.
43. van de Wiel-van Kemenade, E., Ligtenbers, M. J. L., de Boer, A. J., Buijs, F., Vos, H. K., Melief, C. J., Hilkens, J., and Figdor, C. G. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J. Immunol., 151: 767-776, 1993.
44. Wesseling, J., Van Der Valk, S. W., Vos, H. L., Sonnenberg, A., and Hilkens, J. Episialin (MUC1) over-expression inhibits integrin-mediated cell adhesion to extracellular matrix components. J. Cell Biol., 129: 255-265, 1995.
45. Agrawal, B., Krants, M. J., Reddish, M., and Longenecked, B. M. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med., 4: 43-49, 1998.
46. Gum, J. R., Hicks, J. W., Toribara, N. W., Siddiki, B., and Kim, Y. S. Molecular cloning of human intestinal mucin (MUC2) cDNA: identification of the amino terminus and overall sequence similarity to Pre-Pro-von Willebrand factor. J. Biol. Chem., 269: 2440-2446, 1994.
47. Toribara, N. W., Gum, J. R., Culhane, P. J., Lagace, R. E., Hicks, J. W., Petersen, G. M., and Kim, Y. S. MUC-2 human small intestinal mucin gene structure: repeated arrays and polymorphism. J. Clin. Investig., 88: 1005-1013, 1991.
48. Carraway, K. L., and Fregien, N. Mucin structure and function: insights from molecular biology. Trends in Glycoscience and Glycotechnology, 33: 31-44, 1995.
49. Kim, Y. S. Mucin glycoproteins in gastrointestinal malignancies and metastasis. Eur. J. Gastroenterol. Hepatol., 5: 219-225, 1993.
50. Gum, J. R., Byrd, J. C., Hicks, J. W., Toribara, N. W., Lamport, D. T. A., and Kim, Y. S. Molecular cloning of human intestinal mucin cDNAs: sequence analysis and evidence for genetic polymorphism. J. Biol. Chem., 264: 6480-6487, 1989.
51. Ho, S. B., Niehans, G. A., Lyftogt, C., Yan, P. S., Cherwitz, D. L., Gum, E. T., Dahiya, R., and Kim, Y. S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res., 53: 641-651, 1993.
52. Ho, S. B., Shekels, L. L., Toribara, N. W., Kim, Y. S., Lyftogt, C., Cherwitz, D. L., and Niehans, G. A. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res., 55: 2681-2690, 1995.